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Complication of diabetesAbstract In diabetes mellitus dyslipidemia is one of the major risk factors for cardiovascular
disease. In type 2 diabetes mellitus early detection and treatment of dyslipidemia can avoid risk
for cardiovascular disorder. The present study was carried to determine the prevalence and pattern
of hyperlipidemia in patients with hyperglycemia. The cross sectional study was done in different
laboratories of Pakistan, the laboratories served patients referred from different government and
private hospitals between July 2014 and June 2015. All known cases of diabetes mellitus were
evaluated for their lipid proﬁle. Totally 200 diabetic patients were included in the study in which
120 (60%) were males and 80 (40%) were females. Prevalence of dyslipidemia among diabetic males
was 97.18% while for females 87.15%. Among dyslipidemic male the proportion with mixed
dyslipidemic patients was 17.5%, combined two parameters dyslipidemia was 47.5% and isolated
single parameter dyslipidemia was 35%. In females these proportions in mixed, combined two
parameters and isolated single parameter were 16.25%, 51.25% and 32.5%, respectively. Majority
of hyperglycemic patients were dyslipidemic. The most prevalent pattern among male was combined
dyslipidemia with high triglycerides (TG) and low High Density Lipoprotein (HDL) and in female it
was high Low Density Lipoprotein (LDL) and low HDL. The most prevalent lipid abnormality in
our study was low HDL followed by high TG.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes mellitus frequency is increasing many folds in South
Asian population. Many factors like high body fat percentage,
high susceptibility to environmental insulin, high degree of
genetic predisposition and high level of insulin resistance are
Table 1 Number of patients according to different
characteristics.
Characteristics N (%) Characteristics N (%)
Gender Obesity
Male 120 (60%) Obese 84 (42%)
Female 80 (40%) Non-obese 116 (58%)
Age (Years) Hypertension
Below 40 63 (31.5%) Yes 123 (61.5%)
Above 40 137 (68.5%) No 77 (38.5%)
Height Smoking
5–5.2 43 (21.5%) Yes 56 (28%)
5.3–5.5 70 (35%) No 144 (72%)
5.6–5.8 59 (29%) Sedentary lifestyle
5.9–5.11 28 (14%) Yes 86 (43%)
Weight No 114 (57%)
41–50 12 (6%) Work
51–60 52 (26%) Field 93 (46.5%)
61–70 71 (35.5%) Oﬃce 65 (32.5%)
71–80 44 (22%) No 42 (21%)
81–90 21 (10.5%)
762 M. Sarfraz et al.involved in this metabolic disorder (Uttra et al., 2011). It is
characterized by absolute deﬁciency in insulin secretion and
insulin action associated with hyperglycemia, metabolism of
protein, carbohydrate and lipids are disturbed (Abou-Seif
and Youssef, 2004). Different research studies show that body
composition components like lipid proﬁle and body fat are
responsible for the increased prevalence of this disease
(Elinasri and Ahmed, 2008). In diabetes mellitus the lipid
abnormalities are more prevalent because major key enzymes
and lipid metabolism pathways are affected due to deﬁciency
of insulin production and secretion (Taskinen, 2002). Dyslipi-
demia is one of the major risk factors for cardiovascular dis-
ease in hyperglycemic patients. High triglycerides (TG), low
High Density Lipoprotein (HDL) cholesterol, and increased
Low Density Lipoprotein (LDL) cholesterol are the character-
istic feature of diabetic dyslipidemia. Type 2 diabetes affects an
estimated 21 million people in the United States (CDCP,
2013). About 70–80% of diabetic patients will die of cardiovas-
cular disease (ADS, 1998; Feher, 2004). The prevalence of
hypercholesterolemia is not increased in patients with diabetes
mellitus but mortality from coronary heart disease increases
(Mooradian, 2009). American Diabetes Association (ADA)
guidelines recommend maintaining serum levels of TG below
150 mg/dl, LDL cholesterol below 100 mg/dl and HDL choles-
terol of more than 40 mg/dl in males and 50 mg/dl in females
(ADA, 2004).
In the whole world about 382 million people are the victim
of hyperglycemia. The regions of high prevalence are North
America and Caribbean about 11%. According to Interna-
tional Diabetes Federation (IDF) estimates in 2013, 35 coun-
tries out of 219 countries have about 12% prevalence of
diabetes. 10–19% of Asian population is currently affected
due to diabetes. In Pakistan 7.1 million people suffer due to
diabetes. The data from Pakistan showed a prevalence rate
of 18–46% while 46–75% Pakistani patients with diabetes
had metabolic syndrome (Sohail et al., 2006; Basit and
Shera, 2008). The rationale of this study was to detect the lipid
abnormality in hyperglycemic patients because in diabetes mel-
litus early detection and treatment of hyperlipidemia can pre-
vent the progression of lipid abnormalities and minimize the
risk for cerebrovascular accident and cardiovascular disorder.
2. Material and method
2.1. General data
A prospective cross sectional study was planned to analyze the
pattern and prevalence of dyslipidemia in hyperglycemic
patients during July 2014–June 2015. The study was carried
out in different laboratories of Pakistan; a number of patients
were referred from different government and private hospitals.
A total of 200 patients 120 males and 80 females were included
in the study. Diabetes was already diagnosed in all persons.
Information about participants’ age, sex, life style, monthly
income, occupation and family history of diabetes were
recorded. Before registering for the study written consent
was obtained from the participants, expressing their willing-
ness to participate in the study. Patients who have already
taken lipid lowering drug and pregnant women were excluded
from the study. Detailed history and clinical examination of all
the included patients were done.2.2. Blood sample collection
Five milliliters of venous blood samples were collected from
fasting diabetic patients into ﬂuoride oxalate plastic for estima-
tion of blood glucose level and serum was separated by cen-
trifuging the blood samples at 8000 rpm for 10–15 min for
lipid proﬁle analysis including TC, TG, HDL-C, LDL-C.
CHOD-PAP Enzymatic Colorimetric (HUMAN GmbH,
Wiesbaden, Germany) method was used for determination of
lipid proﬁles using the Microtech 3000 plus clinical chemistry
analyzer.2.3. Statistical analysis
All the observations were tabulated and results were expressed
as percentage and mean ± standard error. Data analysis was
performed using mini tab software. To determine the coefﬁ-
cients CHI-SQUARE was used. (P 6 0.05) is signiﬁcant and
(PP 0.05) is not signiﬁcant.3. Results
A total of 200 patients were studied.
3.1. Distribution of patients according to age, height and weight
In this study 31.5% (n= 63) were below 40 years of age while
68.5% (n= 137) were above 40 years and prevalence among
male and female is 95.4% and 86.75%, respectively. According
to the height 43 patients were between 5 and 5.2 inches,
70 were 5.3–5.5 while 59 and 28 persons were fall between
5.6–5.8 and 5.9–5.11 inches, respectively. Most of the patients
in the study had weight 61–70 kg, while 21 and 44 diabetic
persons had 80 kg and 71–80 kg, respectively shown in
(Table 1).
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and sedentary life style
The mean Body Mass Index BMI of study population was
26.6 ± 5.81 (female 26.2 ± 6.81, male 25.5 ± 4.71). 42%
(n= 84) of all diabetic patients were found obese. 61.5%
(n= 123) was hypertensive while 43% (n= 86) had sedentary
life style, 29% (n= 58) males were smoker shown in (Table 1).
3.3. Prevalence and pattern of dyslipidemia
In our study prevalence of dyslipidemia in hyperglycemic
patients was 95%. The most prevalent lipid abnormality was
high LDL (88%) followed by low HDL (71.5%).
Combined dyslipidemia was most common in both male
(47.5%) and female (45.88%). Combined dyslipidemia with
high TG and low HDL (27.5%) was most common in male
while in female high LDL and low HDL (22.5%) were most
common. The second most common pattern was isolated dys-
lipidemia in males (35%) and in females (28.33%). In this dys-
lipidemia high LDL affects 21.6% males and low HDL affects
22.5% females Table 2.Table 2 Pattern of dyslipidemia in male and female.
Pattern of dyslipidemia
Mixed dyslipidemia
(LDLP 100 mg/dl, TGP 150 mg/dl & HDL< 40 mg/dl{male},<50 mg
Combined two parameter dyslipidemia
(a) (LDLP 100 mg/dl, TGP 150 mg/dl & HDL> 40/50 mg/dl)
(b) (LDL< 100 mg/dl, TGP 150 mg/dl & HDL< 40/50 mg/dl)
(c) (LDLP 100 mg/dl, TG< 150 mg/dl & HDL< 40/50 mg/dl)
Isolated single parameter dyslipidemia
(a) (LDLP 100 mg/dl, TG< 150 mg/dl & HDL> 40/50 mg/dl)
(b) (LDL< 100 mg/dl, TGP 150 mg/dl & HDL> 40/50 mg/dl)
(c) (LDL< 100 mg/dl, TG< 150 mg/dl & HDL> 40/50 mg/dl)
Total
LDL: Low Density Lipoprotein, TG: triglyceride, HDL: High Density L
Table 3 Speciﬁc prevalence association of dyslipidemia with age, o
Lipid proﬁle N (%) Age
<40 N (%)
Cholesterol > 200 mg/dl
Male 34 (29.5%) 8 (23.5%)
Female 24 (28.2%) 10 (41.6%)
TG> 150 mg/dl
Male 45 (39.1%) 17 (37.7%)
Female 39 (45.8%) 17 (43.5%)
HDL< 40/50 mg/dl
Male 59 (51.3%) 26 (44%)
Female 53 (62.3%) 13 (24.5%)
LDL> 100 mg/dl
Male 34 (29.5%) 11 (32.3%)
Female 22 (25.8%) 8 (36.3%)
LDL: Low Density Lipoprotein, TG: triglyceride, HDL: High Density L3.4. Prevalence of dyslipidemia association with age, obesity and
hypertension
In our study hyperglycemic male patients with disturbed
cholesterol level were 29.5%, most of them were above the
age of 40, obese and hypertensive were 14 and 21, respectively.
In abnormal triglyceride level out of 45 patients 17 were
<40 years and 28 > 40 years. 53.3% had obesity while 30
were hypertensive. 59 patients had less than 40 mg/dl abnor-
mal HDL level while 34 had increased LDL level (Table 3).
In female abnormal cholesterol was identiﬁed in 28.2%, 10
were <40 years and 14 were >40 years and 75% was hyper-
tensive. 45.8% had greater than 150 mg/dl abnormal triglyc-
eride level, 17 were below 40 years and remaining were above
40 years of age. 16 were obese and 25 had hypertension. With
reduced HDL less than 50 mg/dl 53.18 were obese and 30 suf-
fering from hypertension (Table 3, Figs. 1 and 2).
3.5. Serum lipid profile
Individual serum lipid levels for males and females are shown
in Table 4. In male serum TG was 141.01 ± 36.93, HDL, 38.5Male N (%) Female N (%)
/dl{female}) 21 (17.5%) 13 (16.25%)
18 (15%) 15 (18.75%)
6 (5%) 8 (9.41%)
33 (27.5%) 18 (22.5%)
26 (21.6%) 7 (8.75%)
6 (5%) 0 (0%)
10 (8.3%) 19 (23.75%)
120 80
ipoprotein
besity and hypertension.
Obesity HT
>40 N (%) N (%) N (%)
26 (76.4%) 14 (41.1%) 22 (64.7%)
14 (58.3%) 10 (41.6%) 18 (75%)
28 (24.3%) 24 (53.3%) 30 (66.6%)
22 (56.4%) 16 (41%) 25 (64.1%)
33 (55.9%) 25 (42.3%) 29 (49.1%)
40 (75.4%) 18 (33.9%) 30 (56.6%)
23 (67.6%) 15 (44.1%) 27 (79.4%)
22 (99.9%) 7 (31.8%) 12 (54.5%)
ipoprotein
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Figure 1 Graphical presentation of association of dyslipidemia with obesity and hypertension.
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Figure 2 Graphical presentation of association of dyslipidemia with age.
Table 4 Serum lipid levels in male and female.
Serum lipid level Male Female
Triglyceride 141.01 ± 13.03 147.75 ± 12.16
LDL 121.60 ± 7.16 115.72 ± 6.07
HDL 38.5 ± 4.10 46.64 ± 3.19
LDL: Low Density Lipoprotein, HDL: High Density Lipoprotein
0
20
40
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80
100
120
140
160
180
Triglyceride LDL HDL
Male
Female
Figure 3 Lipid proﬁle in male and female.
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± 34.66, HDL, 46.64 ± 6.89 and LDL, 115.72 ± 17.57 in
female patients (Table 4) (see Fig. 3).
3.6. Prevalence of complications in hyperglycemic patients
In Table 5 prevalence of complications in diabetic patients is
shown. Neuropathy and retinopathy affect 41% and 32%
patients, respectively, 23% patients were suffering from gan-
grene and 20 patients had carbuncles. Among 200 patients
126 were hypertensive (see Fig. 4).4. Discussion
Diabetes mellitus patients have a high prevalence of coronary
artery disease. Coronary artery disease is the most common
Table 5 Complications of hyperglycemic patients.
Complications N (%)
Neuropathy 82 (41%)
Retinopathy 64 (32%)
Nephropathy 62 (31%)
Gangrene 46 (23%)
Carbuncles 20 (10%)
Hypertension 126 (63%)
0 10 20 30 40 50 60 70
Neuropathy
Renopathy
Nephropathy
Gangrene
Carbuncles
Hypertension
Percentage (%)
Percentage (%)
Figure 4 Graphical presentation of complications of hyper-
glycemic patients.
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increased level of serum LDL. The risk of cardiovascular heart
diseases in hyperglycemic patients is two to four times more as
compare to normal. Lipid abnormalities (hyperchylomicrone-
mia, increased level of LDL, VLDL and triglycerides; and
low levels of HDL) are an important cause of atherogenesis
and known as atherogenic dyslipidemia. Lipid abnormalities
may be the result of unbalanced metabolic state of diabetes
and improved control of hyperglycemia does moderate
diabetes-associated dyslipidemia (Ahmad et al., 2008). Two
hundred subjects were recruited for this study and there was
a signiﬁcant difference between the number of male (120)
and female (80) subjects. Majority (68.5%) of the hyper-
glycemic patients were aged above 40 years. The age of dia-
betic patients was observed to be above 40 years conﬁrmed
by earlier workers, their studies reported that age plays a
major role in the risk of developing type 2 diabetes especially
after 40 years (Tagoe and Amo-Kodieh, 2013; Agrawal et al.,
2014). The results showed in the present study that in hyper-
glycemic patients the lipid proﬁle is higher and the similar
results were shown by Agrawal et al. (2014) and Huang
et al. (2014).
In our study prevalence of dyslipidemia was 95% in hyper-
glycemic patients. Two different studies conducted in India
showed the prevalence of dyslipidemia in hyperglycemic
patients was 89% and 92.4% (Udawat et al., 2001; Jayarama
et al., 2012). Prevalence of dyslipidemia in diabetic patients
was 99.13% in males and 89.14% in females, where as in the
study of Jayarama it was 95.40% and 86.75% for male and
female, respectively (Jayarama et al., 2012). In this study high
prevalence of dyslipidemia could be credited to urbanization inthe population from villages. Modernized life style associated
with increasing urbanization, characterized by no physical
activity, change of diet plan causes obesity leads to develop-
ment of diabetes type 2.
The most common pattern of dyslipidemia among males
was combined dyslipidemia with high LDL and low HDL
(27.5%) but in females it was combined dyslipidemia with high
LDL and low HDL (22.5%), this pattern of combined dyslipi-
demia was also studied in another study conducted in South-
ern India by Jayarama, it was found that the prevalence of
dyslipidemia in type 2 diabetes mellitus as a whole in females
was 86.75% with 29.7% single parameter of dyslipidemia,
triglycerides was found in about 56.46% and low HDL was
found in about 72.92% (Jayarama et al., 2012). And the total
prevalence of dyslipidemia and triglyceridemia was found
almost similar to our study group. Isolated dyslipidemia was
the second most common pattern among males it was 35%
and in females 32.5%. The most prevalent lipid abnormality
in our study was high LDL (89.5%) followed by low HDL
(70.5%), whereas in another study conducted in Kuwait iso-
lated dyslipidemia is the second most common pattern with
increased LDL-cholesterol, observed in 21% of the patients
(Al-adasni et al., 2004). Ramu Kandula et al. conducted a
study in Hyderabad (India) showing that prevalence of dyslipi-
demia was 86%, while high total cholesterol was 41%, LDL
was 64%, triglycerides was 47% and low HDL was 71%
(Kandula and Shegokar, 2013). This prevalence of dyslipi-
demia was relevant to our study. A study conducted in Nishtar
Hospital Multan showed that 21% patients with diabetes had
raised serum cholesterol and 34.2% had raised serum triglyc-
eride level (Ahmad et al., 2008), while in another study con-
ducted in 2011, 14% diabetic patients had raised cholesterol
level while 31% patients had raised TG level (Uttra et al.,
2011). In our study high cholesterol level was found in 29%
patients and serum TG found in 42% hyperglycemic patients.
Different values of serum cholesterol may be due to different
dietary habits of people in different cities of the country.
In diabetic patients dyslipidemia was observed in the pre-
sent study and there was a signiﬁcant difference in the levels
of HDL and LDL but when the mean ± standard error of
the variables were separated for male and female patients then
there was no signiﬁcant difference found between them. The
results showed no gender difference in the lipid metabolism
of diabetic patients which was in agreement with the ﬁnding
of Vinter-Repalust et al. (2007). However Gustafsson et al.
reported a signiﬁcant difference in the prevalence of hyper-
glycemic patients between genders (Gustafsson et al., 2004).
According to different survey reports diabetes mellitus has
been one of the most prevailing diseases. Its complications may
cause death directly and indirectly (Wan et al., 2003). Accord-
ing to a survey of 100 patients, 31% hyperglycemic patients
had vision problem, 81% were hypertensive, 40% with neu-
ropathy and 26% had nephropathy (Torangti and Naik,
2000) but in our study most prevalent complication associated
with hypertension secondly neuropathy and then retinopathy
which was about 63%, 41% and 32%, respectively. The com-
plications can be reduced by management of diabetes. Further
research would be done to determine the management of dys-
lipidemia and other complications. Adequate knowledge about
the different factors controlling diabetes and its complications
are important. Improper diet, treatment and life style may be
the leading cause of dyslipidemia and other complications.
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Our study showed common abnormal lipid levels during
hyperglycemia induced dyslipidemia are hypercholesterolemia,
hypertriglyceridemia and elevated Low Density Lipoprotein
cholesterol. Results suggest dyslipidemia is more prevalent in
patients having poor glycemic control which might play a
major role in the development of cardiovascular disease among
diabetic patients. Combined lipid abnormalities are more as
compared to isolated or single abnormality in lipid proﬁle.
Optimal care, routinely monitoring of blood glucose level
and lipid proﬁle should be helpful to cure this abnormality.
Questionnaire for hyperglycemic patients
Hospital name:
Laboratory name:
Date:
(1) Status of patientsNameAgeHeightWeightGenderMaleFemaleWork statusOﬃce workField workMarital statusMarriedSingleDivorced(2) Health statusObesityYesNoDrug intakeYesNoFamily HistoryYesNoOther chronic diseaseYesNoSedentary lifestyleYesNoSmokerYesNo(3) Lab dataNormal value Lab valueBlood glucose level at fastingLipid proﬁleHDL-CLDLTGCholesterolReferences
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